Stressed out? The cancer playbook may help
We often associate the concept of stress with deadlines, emergencies, traffic or hardships. For those who study biological and biochemical processes of disease in cell and organismal models, the idea of stress adaptation is recognized as one mechanism by which malignant and nonmalignant cells survive and thrive within environments that, at times, are hostile.
Are there ways that we think about environmental stress adaptations at an organismal level that may help scientists develop new perspectives on combatting cancer to improve patient outcomes? Indeed, cancer cells may even engage in molecular decision-making activities that differentiate between fight-or-flight responses in the face of environmental stress.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.
This session will consider the mechanisms by which cancer cells adapt to intrinsic and extrinsic stressors and how defining these adaptative mechanisms may lead to improved treatment strategies. Topics will include nutrient access/use, aging, subcellular compartments, microenvironmental influences and tissue reprogramming.
Keywords: Cancer biology, molecular crosstalk, biochemical signaling, tissue homeostasis, aging, subcellular transport, local and global adaptations, tumor microenvironment.
Who should attend: Cancer researchers, cell biologists and biochemists interested in considering how aging, biochemistry and multi-scale adaptations cooperate to shape the stress landscapes of tumors.
Theme song: “Stressed Out” by A Tribe Called Quest
This session is powered by cortisol and catecholamines.

Stress adaptations in tumor progression
Jonathan Kelber (chair), Baylor University
Elda Grabocka, Thomas Jefferson University
Christina Towers, Salk Institute for Biological Studies
Mark LaBarge, Beckman Research Institute of City of Hope
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.